AIM
SGMO

Assured Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Assured Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,472
Closed -$33K – 702
2019
Q1 		$33K Sell
3,472
-4,168
-55% -$42.6K ﹤0.01% 1002
2018
Q4 		$88K Buy
+7,640
New +$94.9K ﹤0.01% 996
2018
Q3 		– Sell
-35,250
Closed -$501K – 1272
2018
Q2 		$501K Sell
35,250
-19,196
-35% -$319K 0.01% 817
2018
Q1 		$1.03M Buy
+54,446
New +$1.16M 0.02% 536

Other funds holding SGMO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Assured Investment Management's SGMO Position: Q2 2019 in Review

Assured Investment Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2019, closing a stake of 3,472 shares — an estimated $33K sold.

Assured Investment Management first reported a position in SGMO in Q1 2018 and held it in 4 quarters. The position peaked at $1.03M in Q1 2018. 185 funds tracked by Wall St. Rank hold SGMO as of Q2 2019.

  • Assured Investment Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 3,472 SANGAMO THERAPEUTICS INC shares in Q2 2019, an estimated $33K.
  • Assured Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2018 and held it in 4 quarters.
  • Assured Investment Management's SANGAMO THERAPEUTICS INC position peaked at $1.03M in Q1 2018.
  • 185 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.